Policy and Advocacy News
Policy and Advocacy News
-
Daily Updates from the 2026 International AIDS Conference
Follow daily updates from the 27th International AIDS Conference, including amfAR news, HIV cure research, prevention advances, and major scientific breakthroughs.
-
Journal of the International AIDS Society Publishes amfAR Analysis of PEPFAR Program Data
Journal of the International AIDS Society publishes amfAR analysis of PEPFAR program data, tracking changes in services and impacts to the HIV workforce following the U.S. foreign aid freeze.
-
amfAR at AIDS 2026: Rethink. Rebuild. Rise.
At AIDS 2026, the 26th International AIDS Conference, amfAR helps power a cutting-edge, collaborative response to HIV across research and advocacy.
-
Taking the Pulse of PEPFAR
A new study by amfAR’s Public Policy Office documents how a withdrawal of U.S. funding for HIV services around the world is impacting the fight against AIDS
-
Ending AIDS Is at Risk
A new report from UNAIDS details where and how the fight against AIDS is faltering due to funding cuts and how the HIV response can rebound
-
For Long-Term Survivors, HIV Is Just a Piece of the Puzzle
amfAR Trustee Phill Wilson reflects on his journey living with HIV for over four decades—his personal losses, his HIV advocacy, and staying on top of his health as he ages.
-
New Agreements for Funding Global HIV Program Miss the Mark
A new amfAR report analyzes how the new Global Health MOUs fail to establish metrics to measure their success.
-
Focus on Key Populations Remains Integral to the HIV Response
A new amfAR report affirms the importance of investing in prevention services that target key populations to decrease new HIV infections
-
Reimagining the AIDS Response to Save Lives in an Era of Disruption
A new UNAIDS report documents existential threats to the HIV response, such as funding cuts and human rights setbacks, and suggests solutions to achieve an end to AIDS.
-
From HIV to Global Cancer Prevention: A New Chapter in Global Health Financing
The Global Cancer Financing Platform is an ambitious new effort to mobilize at least $1 billion by 2030 focused on “stage shifting” or catching cancers earlier. The Platform will raise funds through innovative financing approaches and is based on HIV initiatives such as PEPFAR and the Global Fund
-
When Grants End, So Do Scientific Breakthroughs
New analysis from amfAR’s Public Policy Office assesses the human cost of terminated federal research grants focused on cancer.
-
24 Hours to Save AIDS Research
A global campaign—24 Hours to Save AIDS Research—draws on expertise of researchers and advocates to call for sustained U.S. funding for HIV research.
-
Community-Led Health Programs Benefit People Impacted by HIV
New amfAR-funded study—the SCOPE report—shows how local experts are essential to Global Fund-supported healthcare delivery.
-
Title X Restrictions Harm the U.S. HIV Response
New amfAR analysis of Title X funding restrictions shows that ending the HIV epidemic is jeopardized when federal limits are placed on family planning services.
-
Progress on HIV—Derailed
The latest UNAIDS report shows advances in the global HIV response but warns funding cuts are creating a crisis for millions of people impacted by HIV.